Human Genome Epidemiology Literature Finder
Records 1 - 18 (of 18 Records) |
Query Trace: Waldenstrom Macroglobulinemia and CXCR4[original query] |
---|
SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia. Leukemia research 2009 Sep 33 (9): 1204-7. Poulain Stéphanie, Ertault Marjan, Leleu Xavier, Coiteux Valérie, Fernandes José, Stalnikiewicz Laure, Duthilleul Patrick, Morel Pier |
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 2014 May 123 (18): 2791-6. Treon Steven P, Cao Yang, Xu Lian, Yang Guang, Liu Xia, Hunter Zachary |
TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul . Poulain Stéphanie, Roumier Christophe, Bertrand Elisabeth, Renneville Aline, Caillault-Venet Aurélie, Doye Emmanuelle, Geffroy Sandrine, Sebda Sheherazade, Nibourel Olivier, Nudel Morgane, Herbaux Charles, Renaud Loic, Tomowiak Cécile, Guidez Stéphanie, Tricot Sabine, Roche-Lestienne Catherine, Quesnel Bruno, Preudhomme Claude, Leleu Xavi |
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Annals of hematology 2017 Mar . Cao Xin-Xin, Meng Qi, Cai Hao, He Tian-Hua, Zhang Cong-Li, Su Wei, Sun Jian, Li Yue, Xu Wei, Zhou Dao-Bin, Li Ji |
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. Haematologica 2017 Oct . Varettoni Marzia, Zibellini Silvia, Defrancesco Irene, Ferretti Virginia Valeria, Rizzo Ettore, Malcovati Luca, Gallì Anna, Porta Matteo Giovanni Della, Boveri Emanuela, Arcaini Luca, Candido Chiara, Paulli Marco, Cazzola Mar |
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 7 36 (27): 2755-2761. Treon Steven P, Gustine Joshua, Meid Kirsten, Yang Guang, Xu Lian, Liu Xia, Demos Maria, Kofides Amanda, Tsakmaklis Nicholas, Chen Jiaji G, Munshi Manit, Chan Gloria, Dubeau Toni, Raje Noopur, Yee Andrew, O'Donnell Elizabeth, Hunter Zachary R, Castillo Jorge |
Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing. Clinical lymphoma, myeloma & leukemia 2019 6 19 (8): e496-e505. Shin Dong Woo, Kim Sung-Min, Kim Jung-Ah, Park Hee Sue, Hwang Sang Mee, Im Kyongok, Kim Sungsik, Kim Jinhyun, Kwon Sunghoon, Yoon Sung-Soo, Lee Dong So |
Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact. American journal of hematology 2021 8 96 (12): 1569-1579. Krzisch Daphné, Guedes Nayara, Boccon-Gibod Clémentine, Baron Marine, Bravetti Clotilde, Davi Frédéric, Armand Marine, Smagghe Luce, Caron Jonathan, Bernard Olivier A, Susin Santos, Chapiro Elise, Leblond Véronique, Nguyen-Khac Florence, Roos-Weil Damien, |
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia. Blood advances 2021 5 5 (9): 2438-2446. Tomowiak Cécile, Poulain Stéphanie, Herbaux Charles, Perrot Aurore, Mahé Béatrice, Morel Pierre, Aurran Thérèse, Tournilhac Olivier, Leprêtre Stéphane, Assaad Souad, Villemagne Bruno, Casasnovas Olivier, Nollet Delphine, Roos-Weil Damien, Chevret Sylvie, Leblond Véroniq |
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia. Neoplasia (New York, N.Y.) 2021 3 23 (4): 361-374. Wang Yingjun, Gali Vasantha Lakshmi, Xu-Monette Zijun Y, Sano Dahlia, Thomas Sheeba K, Weber Donna M, Zhu Feng, Fang Xiaosheng, Deng Manman, Zhang Mingzhi, Hagemeister Fredrick B, Li Yong, Orlowski Robert Z, Lee Hans Chulhee, Young Ken |
Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia. Cytometry. Part B, Clinical cytometry 2021 2 102 (1): 62-69. Gayet Mylene, Leymarie Vincent, Derouault Paco, Guérin Estelle, Vaidié Julien, Pascal Virginie, Boulin Mélanie, Dmytruk Nataliya, Chauzeix Jasmine, Trimoreau Franck, Gachard Nathalie, Feuillard Jean, Rizzo Dav |
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy. Blood advances 2021 12 6 (3): 1015-1024. Castillo Jorge J, Sarosiek Shayna R, Gustine Joshua N, Flynn Catherine A, Leventoff Carly R, White Timothy P, Meid Kirsten, Guerrera Maria L, Kofides Amanda, Liu Xia, Munshi Manit, Tsakmaklis Nicholas, Hunter Zachary R, Patterson Christopher J, Branagan Andrew R, Treon Steven |
Venetoclax in Previously Treated Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 11 40 (1): 63-71. Castillo Jorge J, Allan John N, Siddiqi Tanya, Advani Ranjana H, Meid Kirsten, Leventoff Carly, White Timothy P, Flynn Catherine A, Sarosiek Shayna, Branagan Andrew R, Demos Maria G, Guerrera Maria L, Kofides Amanda, Liu Xia, Munshi Manit, Tsakmaklis Nicholas, Xu Lian, Yang Guang, Patterson Christopher J, Hunter Zachary R, Davids Matthew S, Furman Richard R, Treon Steven |
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets. Neurology(R) neuroimmunology & neuroinflammation 2023 5 10 (4): . Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Cinzia Candiotto, Claudia Baratè, Alessandro Cellini, Roberta Bertorelle, Gabriele Siciliano, Livio Trentin, Chiara Bria |
Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia. Hematology/oncology clinics of North America 2023 5 . David F Moreno, Carlos Fernández de Larr |
Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar. Acta haematologica 2023 3 . Awata-Shiraiwa Maaya, Yokohama Akihiko, Kanai Yukihiro, Gotoh Nanami, Kasamatsu Tetsuhiro, Handa Hiroshi, Saitoh Takayuki, Murakami Hirokazu, Hirato Junko, Ikota Hayato, Tsukamoto Norifu |
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere 2023 11 7 (11): e976. Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B van Spriel, Ellen van der Spek, Johannes F M Pruijt, Leonie I Kroeze, Konnie M Hebeda, Sandra Croockewit, Wendy B C Stevens, J Han J M van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheij |
Ibrutinib and venetoclax as primary therapy in symptomatic treatment naïve Waldenström macroglobulinemia. Blood 2023 11 . Jorge J Castillo, Andrew R Branagan, David Sermer, Catherine Flynn, Kirsten E Meid, Megan Little, Katherine Stockman, Timothy P White, Alexa G Canning, Maria Luisa Guerrera, Amanda Kofides, Shirong Liu, Xia Liu, Kris Richardson, Nicholas Tsakmaklis, Christopher J Patterson, Zachary R Hunter, Steven P Treon, Shayna Sarosi |
- Page last reviewed:Feb 1, 2024
- Content source: